Beginner's Mind
Discover the Secrets of Deep Tech Success with Christian Soschner
Discover the strategies and mindsets that transform cutting-edge deep tech ideas into thriving businesses. Christian Soschner delves into the world of deep tech, exploring how entrepreneurs and investors build value and navigate the unique challenges of breakthrough industries.
Each episode features candid conversations with top investors, industry disruptors, and insightful book reviews – dissecting the strategies behind success, observed through my lens, shaped by 35+ years of building organizations and insights from ultrarunning, chess, and martial arts.
Expect:
- Investor Insights: Learn from experts who fund innovation, identifying opportunities and mitigating risk.
- Entrepreneurial Journeys: Go behind-the-scenes with founders turning deep tech concepts into impactful companies.
- Relevant Book Reviews: Discover actionable wisdom from biographies, strategy guides, and thought-provoking reads.
- Focus on Impact: Understand the business models, investment strategies, and market trends that fuel deep tech's potential for real-world impact.
Whether you're building the next big thing, investing in it, or keen on understanding this transformative space, this podcast is your guide to success in the world of deep tech.
Join the community and shape the conversation: https://lsg2g.substack.com/
Beginner's Mind
#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed
These days there is a lot of discussion about the development of diagnostics, therapeutics, and vaccines against the Coronavirus and its disease COVID 19. Viruses are one threat to the health of human beings, and bacteria are another one. Traditionally, bacterial infections are treated with antibiotics, and recently, some bacteria have developed antibiotic resistance.
The WHO describes that Antibiotic resistance is one of the biggest threats to global health, food security, and development today. (https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance)
Phagomed (https://www.phagomed.com/) is developing a novel approach to treat bacterial infections without antibiotics. How that works, the challenges a company has to face while developing novel drugs, and why not all viruses are evil, you will hear in this episode.
Timestamps:
(00:00) Opening
(02:26) Intro Alexander Belcredi
(03:30) Foundation of Phagomed
(06:45) Phages – An Alternative to Antibiotics
(08:10) The Different Types of Viruses
(09:20) Why Are There Not Sufficient Solutions against Bacterial Infections?
(10:50) Competitive Landscape in the Anti-bacterial Industry
(12:30) Status of Clinical Development of Phage-Based Therapies in April 2020
(14:35) Are there Registered Phage-Based Therapies on the Market in 2020?
(16:30) How Capital Intensive is the Development of Phage-Based Therapies
(18:15) Funding Sources For Early-Stage Companies in Europe
(20:00) How to Prepare for Fundraising?
(23:30) When is the right time to go on the Market for Fundraising?
(25:00) What are the right expectations for fundraising processes? What is the success rate?
(30:45) What was the biggest challenge for Phagomed in Fundraising Phases?
(32:30) Is there a suitable time for Fundraising?
(35:20) How Long Does it Take from Starting a Financing Round to The Closing?
(36:55) Raising a Series A in 2020 – Resulted in an Acquisition in 2021
(37:55) Milestone Planning for a Series A Round
(39:05) European Public Funds to Leverage Private Investments
(42:25) What Advice Would you Give Your Younger Self Who Is at the Beginning of His Journey?
Shownotes @ PodcastNotes:
Link
More information:
https://www.phagomed.com/
https://www.lifescienceget2gether.com/
https://linktr.ee/soschner
Video to the episode:
https://youtu.be/YHTR8yMoC3w
Do you want to learn more about life science?
Join exclusive future webinars and member-only events: Become a member of the LSG2G Network.
Join today: https://lsg2g.substack.com/subscribe
Join the Podcast Newsletter: Link
